Panic disorder (PD) is characterized by recurrent and uncontrollable panic attacks associated with behavioral changes and/or persistent anxiety due to the attacks. The development of behavioral models in animals is important for the understanding of the psychobiological and behavioral bases of PD. The present article reviews the main models used in the current literature. Biobehavioral assays used in rats and mice include fear conditioning (which presents moderate predictive, face, and construct validities); the elevated T-maze (which presents good predictive validity, but low face and construct validities); electrical stimulation of the periaqueductal gray (which presents good face validity, but moderate construct validity); predator exposure models (which present good predictive and moderate construct validity); and hypercapnia-induced responses (which present moderate construct validity). These three approaches seek coherence with theories on fear as a way to increase its translational potential; thus, while the elevated T-maze is supported by the Deakin/Graeff theory, the mouse defense test battery relies on the concept of defensive distance, and periaqueductal gray stimulation is based on the functional neuroanatomy of fear. Moreover, to higher or lower degree the three models are supported by an "etho-experimental" approach, with careful observation of animal behavior as a way of discriminating different defensive strategies that model different aspects of anxiety, fear, and panic. These assays can be used, in conjunction with independent variables that attempt to simulate the vulnerabilities and stressors which lead to panic attacks, to produce true models of PD. Finally, an alternative/complementary model is proposed that uses zebrafish alarm reaction to study this disorder.
Introduction

1
Panic disorder (PD) is characterized by recurrent and unexpected panic attacks that are 2 associated with behavioral changes and/or persistent anticipatory anxiety due to these 3 attacks (American Psychiatric Association, 2013) . Panic attacks occur involuntarily and, 4 although they have unknown causes, there is evidence that, for the majority of patients, 5 moderate phobic or hypochondriac symptoms precede the attacks (Craske, Miller, 6 Rotunda, & Barlow, 1990; Fava, Grandi, & Canestrari, 1988) ; after the first attack 7 occurs, the individual often begins to worry about the possibility of the occurrence of 8 new attacks, and this recurrent worry or anticipatory anxiety increases avoidance 9 strategies, but the timing of its occurrence remains unpredictable. It was proposed, 10 then, that panic attacks are "unpredictable" rather than "unexpected" (Barlow, 2002) . 11 Besides symptom phenomenology, PD differs from other anxiety disorders due to its 12 particular pharmacological response (Klein, 1964 (Klein, , 1981 and, partially, due to the 13 independent structure of genetic and environmental risk factors (Gratacòs et al., 2007) . 14 Figure 1 . Basic circuits involved in panic attacks, panic disorder, and normal fear. The "fear pathway" involves forebrain and midbrain circuits that converge onto the dorsal periaqueductal gray area (DPAG) to produce fear-and panic-like behavioral outputs. This system interacts with a "panic inhibition system", involving a central amygdala (CeA)-raphe (lwDR) circuit that leads to serotonin release in the DPAG, inhibiting panic-like responses through a direct and an indirect pathway. The panic inhibition system has acid-sensing neurons which decrease the activity of this system, decreasing the inhibition in the presence of hypercapnia or acidic pH, and triggering a panic attack. Abbreviations: Cg -cingulate cortex; BLA -basolateral amygdala; CeA -central amygdala; MHmedial hypothalamus; DPAGdorsolateral periaqueductal gray area; lwDR -lateral wings of the dorsal raphe nucleus; 5-HT -serotonin; GABA -γ-aminoburytic acid; CRF -corticotropin releasing factor. (dPAG) (Brandão, Anseloni, Pandóssio, De Araújo, & Castilho, 1999; Canteras, 2002; 31 Cezario, Ribeiro-Barbosa, Baldo, & Canteras, 2008; Gross & Canteras, 2012; LeDoux, 32 2003; LeDoux & Pine, 2016; Sukikara, Mota-ortiz, Baldo, Felício, & Canteras, 2006) .
33
The electrical stimulation of these areas elicits a response pattern that characterize 34 what is usually termed a defense reaction, and usually accompanies aversive subjective 35 states characteristic of fear and anxiety (Brandão, Troncoso, de Souza Silva, & Huston, 36 2003) . The functioning of this aversive brain system can also be related to panic attacks. 37 The electrical stimulation of dPAG elicits behaviours similar to the defense reaction as 38 well as subjective and neurovegetative phenomena that resemble a panic attack not only 39 in experimental animals, but also in humans (Graeff & Del-Ben, 2008; Graeff, Silveira, 40 Nogueira, Audi, & Oliveira, 1993; Jenck, Moreau, & Martin, 1995; Lovick, 2000) . avoidance, triggering risk assessment behavior; these patterns are controlled by 53 septo-hippocampal system and posterior cingulate (R. J. Blanchard & Blanchard, 1988; 54 Deakin & Graeff, 1991; Gray & McNaughton, 2003; LeDoux, 1998 The representational nature of animal models demands that its adequacy as an 57 hypothesis-generating device is satisfactory (Belzung & Lemoine, 2011; Maximino & van 58 der Staay, 2019; van der Staay, 2006; Willner, 1986 Willner, , 1991 . This is the issue of validity. 59 The act of modeling is the application of an independent variable -the simulation of a 60 disorder in non-human animals based on knowledge of the etiology and mechanisms of 61 the disease in humans -and the observation of a series of endpoints (dependent 62 variables) (Maximino & van der Staay, 2019; van der Staay, 2006; van der Staay & 63 Steckler, 2001 ). In the literature, sometimes tests are referred to as models, but most of 64 the behavioral tests that are used in the field represent endpoints that are not 65 model-specific. While screenings tests and biobehavioral assay need adequate validity at 66 the predictive and face levels, "true" models rely on good construct validity (Maximino 67 & van der Staay, 2019) . While many definitions of construct validity have been offered, 68 its translational relevance is at least dependent on whether the model has a sound 69 theoretical basis (Maximino & van der Staay, 2019; McNaughton & Zangrossi Jr, 2008; 70 van der Staay, 2006; van der Staay, Arndt, & Nordquist, 2009; van der Staay, Nordquist, 71 & Arndt, 2017) . As a result, a model is as good as is the theory underlying the disease 72 it is targeting, and a true behavioral model is dependent on knowledge regarding 73 etiology and on the neurobehavioral mechanisms underlying the disorder.
74
Predictive validity is usually reduced to pharmacological isomorphism, the 75 congruence between clinical effects and drug effects in the animal tests. In the 76 pharmacotherapy of PD, drugs with clinical efficacy include triazolobenzodiazepines, 77 monoamine oxidase inhibitor, tricyclic antidepressants, and selective serotonin reuptake 78 inhibitor (SSRIs) (Mitte, 2005) . The triazolobenzodiazepines belong to the group of 79 drugs called benzodiazepines that act by binding at the interface of the α and γ 80 subunits of the GABA A receptor. They are efficacious in the short-term treatment of 81 panic disorder, but have largely been replaced by SSRIs as the first-line 82 pharmacotherapy and are generally not regarded as appropriate for long-term therapy. 83 The SSRIs were developed in the early 1970s. All SSRIs possess relatively high affinity 84 for serotonin uptake sites. Imipramine is an antidepressant drug that can be used in the 85 treatment of panic disorder, and belongs to the group of tricyclic antidepressants that 86 act blocking both the serotonin transporter and the norepinephrine transporter. The 87 role of imipramine was initially evidenced during a psychopharmacological experiment 88 in which one group of patients referred for "tranquilizers", as they were very "anxious" 89 and unable to respond to treatment with phenothiazines and sedatives, had the panic 90 attacks ceased by tricyclic antidepressant imipramine treatment (Klein, 1964) .
91
Moclobemide is a antidepressant drug that act as a reversible inhibitor of 92 monoamine-oxidase-A, two comparative trials demonstrated moclobemide to be as 93 efficacious as fluoxetine in patients suffering from panic disorder (Mitte, 2005) .
94
Pharmacologically isomorphic tests and models of PD, then, need to be sensitive to 95 treatment with SSRIs, MAOis, tricyclic antidepressants, and triazolobenzodiazepines.
96
Models of PD, as will be shown, are associated with construct validity on at least 97 two points: the first is the relationship between PD and theories of fear, and the second 98 to specific theories of disordered fear responses in PD. Neurobehavioral theories of PD 99 ans its relations to fear suggest that the disorder is due to disfunctions in circuits that 100 control normal fear (Coplan & Lydiard, 1998; Santos, D'Amico, & Dierssen, 2015) . Fear 101 is thought to be organized at different levels of a circuit, organized in a rostrocaudal pathway, that includes amygdaloid subnuclei, the medial hypothalamus, and portions of 103 the periaqueductal gray area (PAG) (Gross & Canteras, 2012) , receives inhibitory 104 control from regions of the prefrontal cortex (Jovanovic & Norrholm, 2011) , and receives 105 modulatory influence from monoamines such as serotonergic neurons from the raphe 106 (Abrams, Johnson, Hollis, & Lowry, 2004; Hale & Lowry, 2011 McNaughton, 2003; McNaughton & Corr, 2004; Perkins, Kemp, & Corr, 2007; Perusini 112 & Fanselow, 2015) . Consistent with these theoretical propositions, generalized anxiety 113 disorder is distinct from, e.g., panic disorder in phenomenology (worry vs. sense of 114 imminent danger), neural bases, and neurochemistry -including responsiveness to 115 serotonergic drugs (Barlow, 2002; Barlow, Chorpita, & Turovsky, 1996; Klein, 1981) .
116
Specific theories of PD have been proposed which include behavioral and neuronal 117 events (Barlow, 2002; Fava & Morton, 2009; Pilecki, Arentoft, & McKay, 2011; Roth, 118 Wilhelm, & Pettit, 2005 avoidance, while cognitive symptoms are predictors of worry due to panic. It has been 130 criticized because of its putative failure to identify abnormal physiological mechanisms 131 underlying dyspnea during panic attacks (Roth et al., 2005) . However, there has been 132 considerable progress in that area, as physiological and psychobiological research 133 advances. The ventral respiratory group of the brainstem has been identified as a site 134 that detects CO 2 -associated pH changes (Mulkey et al., 2004; Nattie & Li, 1996; Paul, 135 Johnson, Shekhar & Lowry, 2014) , but responses in more rostral regions, including 136 regions in the midbrain (tegmentum, parabrachial nucleus, and periaqueductal gray), 137 hypothalamus, as well as limbic and paralimbic areas (amygdala and periamygdalar 138 nuclei, cingulate, parahippocampal, and fusiform gyri, anterior insula) are reported in 139 neuroimaging studies with healthy humans (Brannan et al., 2001) , suggesting a 140 distributed network involved in the affective representation and/or emotional regulation 141 of breathing. In addition to this ventral hindbrain-limbic circuit, the role of other 142 regions in pH-sensing has been suggested as well. A "panic inhibition system" in the 143 lateral wings of the serotonergic dorsal raphe nucleus (that projects to the dorsal PAG) 144 has been described (Paul et al., 2014) that is activated by hypercapnic stimuli (Johnson, 145 Hollis, Moratalla, Lightman, & Lowry, 2005) . Using dynamic T1ρ relaxation imaging, C allele increases the risk of PD, with a moderate effect.
155
Originally a modification of Klein's model, Gorman's neuroanatomical theory 156 (Dresler et al., 2013; Gorman et al., 2000; Gorman, Liebowitz, Fyer, & Stein, 1989) has 157 high heuristic value for the development of translationally relevant animal models, and 158 considerably good construct validity. The "revised model" postulates that panic attacks 159 are analogous to conditioned fear responses, and are mediated by a fear network that is 160 centered in the amygdaloid nuclei and its connections to the hippocampus, medial 161 prefrontal cortex, hypothalamus, and periaqueductal gray area (Gorman et al., 2000) .
162
Increasing overall serotonergic neurotransmission would normalize the "abnormal 163 sensitivity" of these circuits in patients with PD by inhibiting noradrenergic neurons in 164 the locus coeruleus and reducing transmission to the PAG. Panic attacks can be 165 triggered either by misinterpretation of visceral afferents (including CO 2 -associated pH 166 changes) or by association of context with previously occurring panic attacks.
167
In parallel to this panic-eliciting circuit that is superimposed on the "fear" circuit, a 168 "panic inhibition circuit" has been proposed (Paul et al., 2014) . Normal functioning of 169 this circuit leads to a "return to normal" when the threatening stimulus is no longer (Johnson et al., 2005) . In PD, this circuit is dysfunctional, and is no longer able 179 to counteract the action of the fear circuit (Paul et al., 2014) . This model relies on the 180 Deakin/Graeff theory of the role of serotonin in anxiety and fear (Deakin & Graeff, 181 1991; Graeff, Guimarães, de Andrade, & Deakin, 1996) . Evidence-based causal model of PD. Early life experiences and anxious traits combine to cause Anxiety Sensitivity, a trait that describes a vulnerability to aversive bodily sensations, including the aversive respiratory experiences that lead to hypercapnia. When the individual experiences hypercapnia, an abnormal activation of the fear circuitry leads to catastrophic cognitions regarding threat and the imminence of death, as well as to the activation of the hypothalamus-pituitaryadrenal (HPA) axis. These catastrophic cognitions establish the occasion for strategic avoidance strategies that reduce the activation of the fear circuitry, but perpetuate PD by inducing recurrent worry or anticipatory anxiety, as well as agoraphobic avoidance. cognitions. Avoidance learning, however, can be an important factor in the development 207 of the other symptoms of PD, including agoraphobia and/or other avoidance strategies. 208 This model does not make direct reference to the neurocircuitry that is involved in 209 responses, but tries to explain the role of early life adverse experiences in the 210 development of PD; however, there is no reason to discard the circuitry that was 211 described above.
212
3 Endpoints for modeling panic disorder.
213
The development of animal models for panic disorder is needed to establish the 214 psychological and biological bases of this disorder, as well as to allow the development 215 of novel therapeutics. Differently from models for generalized anxiety and biobehavioral 216 tests for anxiety -that present a myriad of formats and exploit a diversity of different 217 behaviors (Belzung & Lemoine, 2011; Griebel & Holmes, 2013 (Moreira et al., 2013) . In rodents, five main strategies have be used as endpoints to 
236
Conditional fear responses have been widely used to establish fear-like responses and to 237 elucidate the neural bases of these responses (LeDoux, 1998; Schafe, Nader, Blair, & 238 LeDoux, 2001 ). In fear conditioning, animals learn to associate a previously neutral 239 stimulus (CS) with an aversive unconditioned stimulus (US, such as an electrical shock 240 (LeDoux, 2003; Pavlov, 1927) . In cued fear conditioning, the CS is explicit and reliably 241 predicts the US, acting as a cue or signal; in contextual fear conditioning, animals 242 display a defensive reaction (usually freezing) when introduced to a context (e.g., 243 apparatus or chamber) in which they have been previously exposed to the US, and 244 therefore the context represents a complex CS (Davis, Walker, Miles, & Grillon, 2009) . 245 Typically, rats and mice display a initial activity burst to the footshock followed by 246 freezing (LeDoux, 1998); reexposure to the CS in the absence of the US triggers memory 247 retrieval, which initiates reconsolidation and extinction processes. Erhardt et al., 2011; Howe et al., 2015; Mors et al., 2012; Otowa et al., 262 2012; Otowa, Tanii, et al., 2009; Otowa, Yoshida, et al., 2009) , has been recently found 263 to be associated in murine fear conditioning in a quantitative trait loci panel (Knoll, 264 Halladay, Holmes, & Levitt, 2016) , and female mice with humanized COMT Val158Met 265 polymorphism show reduced contextual fear, increased cued fear, and reduced 266 extinction recall (Risbrough, Ji, Hauger, & Zhou, 2014) . A role for serotonin (5-HT) has 267 also been suggested in conditional fear processes (Homberg, 2012) : acute treatment 5-HT appears to exert opposite effects on contextual and cued fear (Homberg, 2012) .
273
While consistent with the idea that contextual fear is more related to anxiety than fear, 274 these results are actually opposed to what is observed in other models (Table 1) .
275 Table 1 . Effect of serotonergic drugs on putative models of fear and panic-like behavior. Abbreviations: ETM: Elevated T-mazed; MDTB: mouse defense test battery; PAG: periaqueductal gray area; SSRIs: selective serotonin reuptake inhibitors.
SSRIs (acute) 5-HT
1A R 5HT 2A R 5-HT 2C R Cued fear ↑ ? ↑ ↓ Contextual fear ↓ ↓ ↑ ? ETM escape ↓ 0 0 0 MDTB 0 0 0 0 PAG stimulation ↓ ↓ (local injection) ↓ (local injection) 0 (injection) Zebrafish alarm reaction ↓ 0 ↓ ?
Elevated T-maze.
276
The elevated T-maze (ETM) is derived from the biobehavioral assay for anxiety that is 277 most widely used contemporaneously -the elevated plus-maze -, and is explicitly based 278 on the Deakin/Greaff hypothesis on the role of 5-HT on defensive behavior (Graeff, (Viana, Tomaz, & Graeff, 1994) . In an ETM session, the rat executes two tasks:
285 inhibitory avoidance and escape. First, the animal is transferred to the end of the closed 286 arm, and the latency to leave this arm is measured; after 30 s intervals, the task is 287 repeated twice, and increased latency to leave the closed arm is interpreted as the 288 acquisition of inhibitory avoidance (Graeff et al., 1998) . After this inhibitory avoidance 289 task, the animal is positioned at the end of one of the open arms to measure the escape 290 response (Viana et al., 1994) . These two responses -inhibitory avoidance and escape -291 recruit different neuronal circuits (Silveira, Zangrossi Jr, Viana, Silveira, & Graeff, 2001 ) 292
and present opposite 5-HTergic modulation (Graeff, Viana, & Mora, 1996; Sena et (Graeff et al., 1998) . Moreover, the assay appears to present 296 good predictive validity for anxiolytic and panicolytic drugs (Graeff et al., 1998 ). An 297 important critique to the model, however, is its low face validity: the association of
298
escape from the open arm to panic attacks is tenuous, given that the escape observed in 299 the ETM is slow, directed, and controlled -very different from escape responses which 300 are observed in other models (Moreira et al., 2013) . Moreover, while escape in the ETM 301 appears to work as a biobehavioral assay -that is, as a tool to investigate normal fear 302 responses, considering the involvement of structures which are associated with fear, as 303 well as the predictive validity of the method -, its construct validity for PD is low, as it 304 makes no explicit reference to etiology of to neurobehavioral mechanisms of panic (as 305 opposed to normal fear). The mouse defense test battery (MDTB) evaluates the behavior of mice exposed to a 308 natural predator, the rat, at different defensive distances (D. C. Blanchard, Griebel, & 309 Blanchard, 2001; Yang et al., 2004) . The mouse is positioned in an oval runway, and an 310 anesthetized rat is manipulated by the experimenter so that its approaches the mouse at 311 a fixed velocity; when the rat approaches the mouse by about 1 m, the mouse usually escape the stimulus -that are predictive of anxiolytic or panicolytic effects, respectively 328 (Moreira et al., 2013) . Thus, as a biobehavioral assay, the MDTB presents good face 329 and predictive validity. 
331
The electrical or chemical stimulation of the dorsal periaqueductal grey (dPAG) evokes 332 abrupt escape and/or freezing behavior and cardiovascular responses that is reminiscent 333 of a panic attack (Beckett & Marsden, 1995; Brandão, Zanoveli, Ruiz-Martinez, Oliveira, 334 & Landeira-Fernandez, 2008; Schenberg, 2010; Schenberg et al., 2014 behavior interspersed with periods of tense immobility (Brandão et al., 2005 (Brandão et al., , 2003 (Brandão et al., , 342 2008 . Similarly, disinhibiting the medial hypothalamus -a diencephalic structure that 343 composes, along with the periaqueductal gray, the encephalic circuits which mediate 344 fear responses and panic attacks (Canteras, 2002 electrically stimulating these regions in humans, placing its construct validity in the 349 similarity of neuronal circuits (Moreira et al., 2013) . These tests also appear to present 350 a good predictive validity, since panicolytic, but not anxiolytic drugs, alter behavior 351 after stimulation Schenberg et al., 2002) . However, from 352 an etiological point of view, the induction of responses by direct stimulation of brain 353 regions has a tenuous relation to spontaneous panic attacks observed in humans, and no 354 references are made to how dysfunctions in these circuits lead to PD, or on the role of 355 predisposing factors such as anxiety sensitivity, reducing construct validity.
356
In addition to freezing that is observed during dPAG stimulation, post-stimulation 357 freezing is also observed (Brandão et al., 2008) . Interrupting the electrical stimulation 358 of the dPAG at the escape threshold elicits this freezing behavior, that is accompanied 359 by activation of the laterodorsal nucleus of the thalamus, suggesting transfer of 360 information to more rostral structures (Brandão et al., 2008) . This led Brandão et al.
361
(2008) to speculate that post-stimulation freezing is more related to risk assessment, as 362 the animal freezes in order to better accumulate information on threat levels (see also 363 Hagenaars, Oitzl, & Roelofs, 2014); as a result, while stimulation-elicited freezing should 364 be treated as a model for a panic attack, post-stimulation freezing would be a better 365 model for anticipatory anxiety in PD (Brandão et al., 2008) . 
368
Hypersensitivity to CO 2 shows considerable heuristic value for PD models (Battaglia, 369 Ogliari, D'Amato, & Kinkead, 2014), and is able to identify people at heightened risk 370 for PD before the onset of the disorder (Coryell, Pine, Fyer, & Klein, 2006) . If these 371 responses are predictive of the "core" symptoms of PD (panic attacks and avoidance), 372 they can be understood as endophenotypes (Meuret et al., 2006) . Using this 373 information, methods were developed in which hypercapnia-induced behavioral and 374 physiological responses are used in animals (Battaglia & Ogliari, 2005; Battaglia et al., 375 2014; Schenberg et al., 2014) . For example, slow infusion of potassium cyanide (KCN), 376 an agent that induces cytotoxic hypoxia of the arterial chemoreceptor cells (Barros et 377 al., 2002) , induces defensive responses in rats that are similar to that observed with 378 electrical or chemical stimulations of the dPAG (Schimitel et al., 2012) , and 379 sub-threshold doses of KCN facilitate responses elicited by electrical stimulation of the 380 dPAG (Schimitel et al., 2012) . Moreover, unilateral electrolytic lesions of the dPAG 381 inhibit this response, suggesting that this structure is necessary for KCN-elicited 382 responses. Unexpectedly, exposure to either 8% or 12% CO 2 induced respiratory 383 alterations and producing signs of increased arousal in the open field (less exploratory 384 behavior and appearance of exophthalmus), but actually attenuated dPAG-evoked 385 responses, including freezing and flight (Schimitel et al., 2012) . Since the KCN-evoked 386 defensive behaviors were markedly facilitated by the previous exposure to 8% or 12% the lateral wings of the dorsal raphe nucleus (Berquin, Bodineau, Gros, & Larnicol, 392 2000; Casanova, Contreras, Moya, Torrealba, & Iturriaga, 2013; Hayward & Von 393 Reitzenstein, 2002; Johnson et al., 2011 Johnson et al., , 2005 .
394
Interesting advances include modeling the differential sensitivity to hypoxia-or 395 hypercapnia-induced responses in animals. This can be done by using sub-threshold 396 concentrations; for example, rats injected with a sub-threshold concentration of lactate 397 infusions -a substance which in trigger panic attacks in PD patients (Bourin, Malinge, 398 & Guitton, 1995) -show no overt behavioral changes, but display tachycardia, 399 tachypnea, hypertension, and increased anxiety when GABA synthesis in the 400 dorsomedial hypothalamus is chronically inhibited 401 Johnson, Truitt, et al., 2008) . These animals also show attenuated c-Fos-like responses 402 in the lateral wings of the dorsal raphe nucleus (lwDRN) and the VLPAG (Johnson, 403 Lowry, et al., 2008 & Kas, 2011; Kalueff, Ren-Patterson, LaPorte, & Murphy, 2008; Kas, Gelegen, 426 Schalkwyk, & Collier, 2009; Keifer & Summers, 2016; van der Staay, 2006) . 
428
Aiming to enrich the breadth of etho-experimental approaches traditionally made with 429 rodents, the use of non-mammalian species has been proposed (Maximino et al., 2015) . 430 Among these, zebrafish (Danio rerio Hamilton 1822), a cyprinid fish widely used in 431 genetics and developmental biology, has gained traction as a model organism in 432 behavioral research (Gerlai, 2010; Kalueff et al., 2012; Norton & Bally-Cuif, 2010; 433 Rinkwitz, Mourrain, & Becker, 2011; Shams, Rihel, Ortiz, & Gerlai, 2018) . Importantly 434 for the study of fear and panic is the range of defensive responses that are observed in 435 this species, among which the alarm reaction is relatively well-characterized and 436 relevant for modeling PD (Maximino et al., 2018) . This is a response that is initiated in 437 the olfactory system by substances that are released by the damaged skin of produced by specialized skin cells ("club cells") and released after these cells are 441 damaged is of unknown composition (Døving & Lastein, 2009; Jesuthasan & Mathuru, 442 2008), but it presents hypoxanthine 3-N-oxide and chondroitin fragments -substances 443 which mimic part of the behavioral and physiological reactions (Mathuru et al., 2012; 444 Parra, Adrian Jr, & Gerlai, 2009) . During exposure to this substance, an increase in 445 shoal cohesion (Canzian, Fontana, Quadros, & Rosemberg, 2017; Speedie & Gerlai, 446 2008) and the initiation of patterns of erratic swimming followed by freezing (Mathuru 447 et al., 2012; Quadros et al., 2016; Speedie & Gerlai, 2008 ) is observed.
448
Differently from the behavior that is observed during exposure, behavior observed 449 after exposure usually involves increased bottom dwelling associated with erratic 450 swimming and freezing (Cachat et al., 2011; Egan et al., 2009) Htr1a gene, which encodes the 5-HT 1A receptor, increases responsiveness in a cued fear 481 conditioning paradigm (Klemenhagen, Gordon, David, Hen, & Gross, 2006) . These 482 results underline the potential of knockout approaches, widely documented in the last 483 two decades, in unraveling the genetic vulnerabilities through animal models.
484
Early life adversities, including childhood parental loss and stressful life events 485 occurring in childhood and adolescence, are associated with adult CO 2 sensitivity and 486 PD (Battaglia et al., 2009; Ogliari et al., 2010) . Interestingly, Panksepp (1998) approaches. These tests and models vary in terms of validity -for example, the face 508 validity of the elevated T-maze is lower than the other presented models, but its relation 509 to behavioral theories of fear is higher than the models involving electrical or chemical 510 stimulation. Finally, the introduction of new models -including models with 
